medigraphic.com
SPANISH

Revista Cubana de Cirugía

ISSN 1561-2945 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2023, Number 1

Next >>

Revista Cubana de Cirugía 2023; 62 (1)

Surgical treatment of extrahepatic cholangiocarcinoma

Céspedes RHA, Fernández PR, Estopiñam CR
Full text How to cite this article

Language: Spanish
References: 15
Page:
PDF size: 617.69 Kb.


Key words:

extrahepatic cholangiocarcinoma, hilar cholangiocarcinoma, morbidity, mortality, distal cholangiocarcinoma.

ABSTRACT

Introduction: Cholangiocarcinoma is the most frequent biliary tract neoplasm responsible for high morbidity and mortality.
Objective: To determine morbidity and mortality due to extrahepatic cholangiocarcinoma in the surgery service of Hospital Universitario Manuel Ascunce Domenech.
Methods: A descriptive, prospective and observational study was carried out with patients admitted to the general surgery service with a diagnosis of extrahepatic cholangiocarcinoma between September 2018 and January 2022. The study universe consisted of 21 patients who met the inclusion criteria. Descriptive statistical methods and calculations with percentage values were used.
Results: The highest incidence of patients were male and white-skinned, accounting for 71.4% and 85.7%, respectively. Adenocarcinoma predominated as histological variety, representing 85.7 %, together with proximal cholangiocarcinoma and the sclerosing variant of its classification. 71.4 % of the patients were discharged alive and after curative surgery.
Conclusions: Most of the patients were male, white-skinned and from rural origin. The most frequent findings were a proximal location and the sclerosing variant. Over half the patients underwent Hess and Whipple procedure with curative purpose. Biliary leakage, adenocarcinoma as histologic type, and the condition of alive at discharge prevailed in all patients.


REFERENCES

  1. del Valle Llufrío P, Ruesca Domínguez C, Ortega Cárdenas Y, Medina Carabeo E, Rangel Lorenzo E, Cora Estopiñán S. Colangiocarcinoma, diagnóstico, tratamiento y evolución clínica. Presentación de un caso con sobrevida 5 años. Rev. Med. Electrón. 2021 Feb [acceso 06/02/2022];43(1):2986-96. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1684-18242021000102986&lng=es1. . [ Links ]

  2. Alonso Soto J, Martínez Piti A, Díaz Rondón B, Chao González L, Tusen Toledo Y, Barroso Márquez L. Caracterización de los pacientes con tumores de la vía biliar mediante colangiopancreatografía retrógrada endoscópica. Rev cubana med. 2016 Jun [acceso 06/02/2022];55(2):141-9. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232016000200005&lng=es2.

  3. Hidalgo Méndez F. Colangiocarcinoma hiliar (tumor de Klatskin). Rev Clin Med Fam. 2014 Feb;7(1):69-72. DOI: https://dx.doi.org/10.4321/S1699-695X20140001000133.

  4. Guillen VS. Revisión sobre colangiocarcinoma y tumor de Klatskin. Rev Med Cos Cen. 2016;73(620):533-8. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=676674.

  5. D'Alaimo BN, D'Avanzo ZD, Mora MKV. Abordaje del colangiocarcinoma. Revista Médica Sinergia. 2020;5(06):1-11. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=942895.

  6. Krasinskas A. Cholangiocarcinoma. Surg Pathol Clin. 2018;11(2):403-29. DOI: https://doi.org/10.1016/j.path.2018.02.0056.

  7. Oliveira I, Kilcoyne A, Everett J, Mino-Kenudson M, Harisinghani M, Ganesan K. Cholangiocarcinoma: classification, diagnosis, staging, imaging features, and management. Abdom Radiol (NY). 2017;42(6):1637-49. DOI: https://doi.org/10.1007/s00261-017-1094-77.

  8. Khan AS, Dageforde LA. Cholangiocarcinoma. Surgical Clinics of North America. 2019;99(2):315-35. DOI: https://doi.org/10.1016/j.suc.2018.12.0048.

  9. Doherty B, Nambudiri V, Palmer W. Update on the Diagnosis and Treatment of Cholangiocarcinoma. Curr Gastroenterol Rep. 2017;19(1):1-8. DOI: https://doi.org/10.1007/s11894-017-0542-49.

  10. Razumilava N, Gores G. Cholangiocarcinoma. Lancet Gastroenterol Hepatol. 2014;383:1-12. DOI: https://doi.org/10.1016/S0140-6736(13)61903-010.

  11. Ho J, Curley S. Diagnosis and Management of Intrahepatic and Extrahepatic Cholangiocarcinoma. Cancer Treat Res. 2016;121-63. DOI: https://doi.org/10.1007/978-3-319-34244-3_711.

  12. Rizvi S, Gores G. Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma. Clin Gastroenterol Hepatol. 2013;145(6):1215-29. DOI: https://doi.org/10.1053/j.gastro.2013.10.01312.

  13. Mulholland M, Lillemoe K, Doherty G, Upchurch G, Alam H, Pawlik T; illustrations by Holly R. Fischer Greenfield's surgery: scientific principles and practice. Vol 1. 7ma ed. Philadelphia: Wolters Kluwer;2017. [ Links ]

  14. Bartella I, Dufour J. Clinical Diagnosis and Staging of Intrahepatic Cholangiocarcinoma. J Gastrointestin Liver Dis. 2015;24(4):481-9. DOI: https://doi.org/10.15403/jgld.2014.1121.244.chl14.

  15. Blechacz B, Ghouri Y, Mian I. Cancer review: Cholangiocarcinoma. J Carcinog. 2015;14(1):1-12. DOI: https://doi.org/10.4103/1477-3163.15194015.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Revista Cubana de Cirugía. 2023;62